Yes I agree. I LOVE the business model. The time has finally arrived for CYRX. I know it has been a long and difficult time getting to this point. I got a sense of uncertainty and disbelief when I read the board before I joined, like everyone is watching the price go up, but half expecting the worst after years of conditioning. The only uncertainty I have is how accommodative the FDA will be after the first 2 approvals. I wonder if they will take a wait and see approach to see how safe the CAR-T therapy will be on a large scale before opening up the flood gates.
And yes, I read your 21 month cash flow number but think there will be some fluctuations on spending depending on the speed and number of commercializations, so I wouldn’t go that far. I said they would be profitable next year but I meant they will be cash flow positive next year, and I think profitable by the end of 2019.
News 
Market Data 
Discover 
